JP2022550458A5 - - Google Patents
Info
- Publication number
- JP2022550458A5 JP2022550458A5 JP2022520471A JP2022520471A JP2022550458A5 JP 2022550458 A5 JP2022550458 A5 JP 2022550458A5 JP 2022520471 A JP2022520471 A JP 2022520471A JP 2022520471 A JP2022520471 A JP 2022520471A JP 2022550458 A5 JP2022550458 A5 JP 2022550458A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition according
- individual
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909113P | 2019-10-01 | 2019-10-01 | |
| US62/909,113 | 2019-10-01 | ||
| PCT/US2020/053642 WO2021067506A1 (en) | 2019-10-01 | 2020-09-30 | Methods of treating conditions related to the s1p1 receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550458A JP2022550458A (ja) | 2022-12-01 |
| JP2022550458A5 true JP2022550458A5 (https=) | 2023-10-10 |
Family
ID=75337529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520471A Pending JP2022550458A (ja) | 2019-10-01 | 2020-09-30 | Ｓ１ｐ１受容体に関連する状態を処置する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220347158A1 (https=) |
| EP (1) | EP4037678A4 (https=) |
| JP (1) | JP2022550458A (https=) |
| KR (1) | KR20220074913A (https=) |
| CN (2) | CN115038438A (https=) |
| AU (1) | AU2020360413A1 (https=) |
| BR (1) | BR112022005999A2 (https=) |
| CA (1) | CA3156182A1 (https=) |
| IL (1) | IL291654A (https=) |
| MX (1) | MX2022003982A (https=) |
| TW (1) | TW202114656A (https=) |
| WO (1) | WO2021067506A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240134360A (ko) | 2022-01-13 | 2024-09-09 | 아레나 파마슈티칼스, 인크. | 호르몬 치료와 조합되어 s1p1 수용체-연관된 장애를 치료하는 데 사용하기 위한 에트라시모드 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8580841B2 (en) * | 2008-07-23 | 2013-11-12 | Arena Pharmaceuticals, Inc. | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| JP5856980B2 (ja) * | 2010-01-27 | 2016-02-10 | アリーナ ファーマシューティカルズ， インコーポレイテッド | （Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス |
| PL3242666T3 (pl) * | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| BR112017027656B1 (pt) * | 2015-06-22 | 2023-12-05 | Arena Pharmaceuticals, Inc. | Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo |
| MX2019009843A (es) * | 2017-02-16 | 2020-01-30 | Arena Pharm Inc | Compuestos y metodos para el tratamiento de la enfermedad inflamatoria intestinal con manifestaciones extraintestinales. |
-
2020
- 2020-09-30 CN CN202080076189.6A patent/CN115038438A/zh active Pending
- 2020-09-30 BR BR112022005999A patent/BR112022005999A2/pt not_active Application Discontinuation
- 2020-09-30 WO PCT/US2020/053642 patent/WO2021067506A1/en not_active Ceased
- 2020-09-30 US US17/765,619 patent/US20220347158A1/en not_active Abandoned
- 2020-09-30 CN CN202411419528.2A patent/CN119280227A/zh active Pending
- 2020-09-30 JP JP2022520471A patent/JP2022550458A/ja active Pending
- 2020-09-30 AU AU2020360413A patent/AU2020360413A1/en active Pending
- 2020-09-30 CA CA3156182A patent/CA3156182A1/en active Pending
- 2020-09-30 EP EP20873256.0A patent/EP4037678A4/en not_active Withdrawn
- 2020-09-30 TW TW109134240A patent/TW202114656A/zh unknown
- 2020-09-30 MX MX2022003982A patent/MX2022003982A/es unknown
- 2020-09-30 KR KR1020227014194A patent/KR20220074913A/ko not_active Withdrawn
-
2022
- 2022-03-23 IL IL291654A patent/IL291654A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516662A5 (https=) | ||
| CN101980704A (zh) | 选择性s1p1受体激动剂的给药方案 | |
| EP4114466B1 (en) | Treatment of pain and vasoconstriction | |
| JP2005506987A (ja) | 感覚的に許容される口内崩壊性組成物 | |
| JP2022511788A5 (https=) | ||
| JP2020531477A (ja) | 子宮内膜症、子宮筋腫、多嚢胞性卵巣症候群又は腺筋症を治療するための医薬製剤 | |
| JP2023509698A5 (https=) | ||
| JP2022536623A (ja) | 肺動脈性肺高血圧症の治療方法 | |
| JP2021500377A (ja) | 遅延放出デフェリプロン錠剤及びその使用法 | |
| JP2022504181A5 (https=) | ||
| CN102149377A (zh) | 决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途 | |
| JP2023528896A5 (https=) | ||
| JP2022550458A5 (https=) | ||
| WO2006034631A1 (en) | Composition comprising amlodipine and angiotensin ii receptor blocker | |
| JP2024529084A (ja) | 子宮内膜症を治療する方法及び有効な避妊を提供する方法 | |
| JPH10511097A (ja) | 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用 | |
| CN103249415B (zh) | 包含盐酸乐卡地平和缬沙坦的复合制剂及其制备方法 | |
| JP2023531930A5 (https=) | ||
| JP2002523363A (ja) | 慢性疲労症候群および／または線維筋痛の処置のためのサブスタンスｐアンタゴニストの使用および慢性疲労症候群の処置のためのｎｋ−１レセプターアンタゴニストの使用 | |
| JP2003535897A (ja) | アンギオテンシンｉｉアンタゴニストの新規使用法 | |
| JP2003523385A (ja) | 神経変性疾患の治療法 | |
| JP2024532129A5 (https=) | ||
| WO1996004917A1 (en) | Remedy for myotonic dystrophy | |
| CN110325214A (zh) | 用于预防和治疗神经元损伤的低剂量药物组合 | |
| WO2012050539A1 (en) | Pharmaceutical composition comprising eplerenone |